Mark Joseph Murray

Mark Joseph Murray discloses dealings in Arbutus Biopharma Corporation to SEDI. Between 16 June 2016 and 28 November 2018, the trades on record add up to 3 filings.

Purchases make up the whole of the open-market record (1 purchase, €12k). Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 2 option exercises.

The record was last updated on 29 November 2018 with an option exercise (€7,723) in Arbutus Biopharma Corporation. The most recent open-market purchase was published on 21 June 2016, 3,779 days ago. Typically, a trade is published a median of 5 days after it takes place. Until a filing is published, the market cannot know about the trade. Source: insider filings from SEDI. Past trades are no guide to future returns.